↓ Skip to main content
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Immediate Effects of Use of Recombinant Bone Morphogenetic Protein in Children Having Spinal Fusion and Refusion Procedures in United States
Published in
Spine, November 2015
DOI 10.1097/brs.0000000000001110
Pubmed ID
Authors
Abstract

Retrospective study of Nationwide Inpatient Sample (NIS)Objective. Objective of this study is to estimate the prevalence of complications in children who had insertion of recombinant human Bone Morphogenetic Protein (rhBMP) at the time of Spinal Fusion Procedures (SFP) and to examine if the use of rhBMP is associated with an increased risk of complications. Use of rhBMP for SFP has been associated with conflicting safety profile reports in adults. NIS (years 2004-2010) was used. All patients <18 years who had a SFP during hospitalization with or without insertion of rhBMP were selected. Complications were selected based on a literature review of studies examining outcomes of SFP. Association between insertion of rhBMP and occurrence of complications was examined by multivariable logistic regression models. Of the 72,898 children who underwent SFP, 7.1% had insertion of rhBMP. Overall complication rate was 14.34% (15.2% in rhBMP group and 14.3% in no-rhBMP group). There was no statistically significant difference in the overall complication rate (OR = 1.08, 95% CI = 0.89-1.30) or among fourteen different complications between rhBMP and no-rhBMP groups. Children who had rhBMP were associated with higher odds for "other infections" (OR = 2.09, 95% CI = 1.26-3.48, p = 0.004) when compared to their counterparts. Despite the lack of FDA approval, rhBMP was not infrequently used in pediatric SFP. In this large retrospective study using administrative data, the use of rhBMP in children during SFP was not associated with higher risks for majority of assessed complications with the exception of "other infections". Future studies must examine the long-term impact of use of rhBMP in children with SFP.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 3 13%
Professor 3 13%
Student > Bachelor 2 8%
Student > Ph. D. Student 2 8%
Lecturer 1 4%
Other 4 17%
Unknown 9 38%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 9 38%
Nursing and Health Professions 4 17%
Biochemistry, Genetics and Molecular Biology 1 4%
Unknown 10 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2015.
All research outputs
#3,113,450
of 25,373,627 outputs
Outputs from Spine
#886
of 8,451 outputs
Outputs of similar age
#42,067
of 294,811 outputs
Outputs of similar age from Spine
#15
of 112 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,451 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 294,811 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.